Dubai: M42, a leader in global health powered by AI, technology, and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP) for its essential role in the National Campaign for Early Detection of Hypertension (MMM25). This initiative focuses on enhancing preventive healthcare and cardiovascular health across the UAE.
According to Emirates News Agency, MoHAP honored M42 and two of its network centers, Healthpoint and HealthPlus, for their significant contributions to the campaign's achievements. This acknowledgment underscores M42's commitment to managing population health and supporting the UAE's shift toward prevention-led and future-ready healthcare.
MoHAP surpassed its campaign target, completing over 110,000 screenings across the UAE. The campaign's focus on early detection and preventive care highlights the Ministry's success in delivering high-quality proactive healthcare, utilizing reliable digital data to plan and manage public health programs in line with the 'We the UAE 2031' vision.
The campaign aligns with the Ministry's strategy to establish a world-leading health system focused on community health and prevention as core elements of care. Dr. Hussain Abdul Rahman Al Rand, Assistant Undersecretary for the Public Health Sector at MoHAP, emphasized the collective responsibility of public health, involving federal, local, private, and community stakeholders. The campaign's success in transforming field data into strategic indicators enhances the ability to design evidence-based health policies and optimize resources.
Dr. Al Rand highlighted the Ministry's role in planning preventive health policies based on reliable data, promoting partnerships with the private sector, and leveraging innovation and digital infrastructure for resilience in public-health emergencies.
Dimitris Moulavasilis, Group CEO of M42, stated that the campaign participation aligns with M42's belief in prevention and early intervention as the future of healthcare. He noted the importance of coordinating efforts across sectors to advance preventive healthcare in the UAE, contributing to earlier detections and better health outcomes.
Dr. Fernando Macario, Chief Medical Officer at M42, remarked on hypertension as a significant risk factor for cardiovascular disease. He noted the recognition from MoHAP as a testament to M42's dedication to transforming healthcare delivery to proactive models, supporting the national goal of reducing premature deaths by 30% from non-communicable diseases by 2030, in line with the UN Sustainable Development Goals.
Throughout the campaign, M42 mobilized its medical network to deliver screenings and empower individuals to manage their cardiovascular health while raising awareness of hypertension as a leading heart disease risk factor.